Deloitte’s move to bring its healthcare consulting experience to bear through a healthcare analytics channel for providers marks an interesting trend at HIMSS13. Through its alliance with Intermountain Healthcare as an “anchor tenant,” it plans to formally launch the service called Recombinant July 1 — the next fiscal year.
The collaborative analytics platform between Deloitte and Intermountain is designed to help providers benchmark outcomes for their own patients compared with industry performance. Peter Emerson, the principal of the company, said it is merely responding to clients who asked for it and recognized it could provide a useful service to other providers.
Intermountain began seeking out a collaborative partner at the HIMSS conference last year, Emerson said.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“We needed something beyond services and technology …,” Emerson said. “Instead of [just] advising healthcare, we want to be the fabric of it.
The big data comparative analytics tool called Outcomes Miner will focus, at least initially, on analytics-focused tools for chronic conditions like diabetes and heart failure starting this summer. It reflects the pressure for providers to be able to improve patient outcomes and reduce readmissions and healthcare costs.
Asif Dhar, the chief medical information officer and a principal with Deloitte, said the company wants to help providers keep their data analytics in-house where it provides richer information. “Once data is moved to a consolidator away from a health system, the usefulness of that data becomes limited.”
